Daily non-political popular news in brief.

Calming Factor: DNA vaccine for MS passes initial test

A DNA vaccine against multiple sclerosis passes a safety trial and shows signs of suppressing immune-directed nerve damage.

Read more »

Keywords: calming, factor, dna, vaccine, passes, initial, test, passe

« Previous | Next »

Similar news on "Calming Factor: DNA vaccine for MS passes initial test":

1. Nice Shot: Hepatitis E vaccine passes critical test
   03-03-2007 · Science News Online
   An experimental vaccine for hepatitis E has proved nearly 96 percent protective in a test in Nepalese soldiers.
   Similar news · Read more »
   
2. NIAID DNA vaccine for H5N1 avian influenza enters human trial
   01-03-2007 · EurekAlert!
   The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD. Scientists from the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), one of the NIH Institutes, designed the vaccine. The vaccine does not contain any infectious material from the influenza virus.
   Similar news · Read more »
   
3. Fever after smallpox vaccination tied to individual genetic variations
   06-18-2007 · EurekAlert!
   St. Louis researchers have identified common DNA variations that underlie susceptibility to fever after smallpox vaccination. Their finding is the first to link individual differences written into the genetic code with a vaccine-related complication -- albeit a mild one.
   Similar news · Read more »
   
4. UA researchers identify new adherence factor, Pili, produced by tuberculosis
   03-05-2007 · EurekAlert!
   Researchers at the University of Arizona College of Medicine’s Department of Immunobiology have discovered that the agent that causes tuberculosis (TB), Mycobacterium tuberculosis, produces a new type of virulence factor called Mycobacterium Tuberculosis Pili (MTP). Their findings suggest that MTP could be a promising, new TB-vaccine candidate. Worldwide, three million people die each year from tuberculosis and an estimated 1.2 billion are infected with the bacteria.
   Similar news · Read more »
   
5. Propane fuel cell passes muster at Exit Glacier Nature Center
   11-10-2006 · EurekAlert!
   The Alaska Energy Technology Development Laboratory at the University of Alaska Fairbanks recently announced a successful field test of a prototype propane fuel cell.
   Similar news · Read more »
   
6. Rapid, Low-Cost DNA Testing
   01-05-2007 · EurekAlert!
   University of Rochester Professor Lewis Rothberg received a NYSTAR grant to continue working on a recent discovery by his group: how to rapidly test DNA to improve our health and make sure we're drinking clean water and eating uncontaminated food. Rothberg's new method can help forensics labs identify criminals, test water, and identify harmful genetic sequences in medical research. Rothberg's innovative procedure quickly and inexpensively identifies genetic sequences in any sample of DNA.
   Similar news · Read more »
   
7. New Lancet study: Malaria vaccine candidate has promising safety, tolerability profile in infants
   10-17-2007 · EurekAlert!
   The first study to test GlaxoSmithKline's (GSK) investigational RTS,S/AS02 malaria vaccine in African infants serves as the first proof of concept in this population that the vaccine has a promising safety and tolerability profile and reduces malaria parasite infection and clinical illness due to malaria, according to a paper published today online in the Lancet.
   Similar news · Read more »
   
8. DNA clues to inform conservation in Africa
   05-22-2007 · EurekAlert!
   Tracing the evolutionary history of wildlife could improve global habitat conservation, a major Cardiff University study has found. Researchers in the School of Biosciences analysed the African bushbuck -- a common species which lives in most sub-Saharan habitat types -- to test whether DNA similarity between populations living in different habitats can reveal the similarity of those ecoregions now and in the past.
   Similar news · Read more »
   
9. Abnormal glutamine repeats interfere with key transcription factor, leading to neurodegeneration
   11-13-2007 · EurekAlert!
   Although repeating sequences of three nucleotides encoding some of the bodies' 20 amino acids are a normal part of protein composition, abnormal expansion of trinucleotide repeats is the known cause of multiple inherited neurodegenerative disorders, including Huntington disease. In research with mice, scientists now have discovered more specific information about how this inherited expansion of a normal repeated DNA sequence alters gene expression.
   Similar news · Read more »
   
10. Gene found to play a suppressor role in skin cancer development
    02-06-2008 · EurekAlert!
    Researchers at the Burnham Institute for Medical Research have provided genetic evidence that Activating Transcription Factor 2 plays a suppressor role in skin cancer development. ATF2 is a protein that regulates gene transcription, the first step in the translation of genetic code, in response to extracellular stresses such as ultraviolet light and ionizing radiation. This function of ATF2 in stress and DNA damage response suggests it may also play a role in tumor formation.
    Similar news · Read more »